Lo Nigro Antonio, Gallo Alessia, Bulati Matteo, Vitale Giampiero, Paini Diego Sebastian, Pampalone Mariangela, Galvagno Daniele, Conaldi Pier Giulio, Miceli Vitale
Ri.MED Foundation, Palermo, Italy.
Research Department, Mediterranean Institute for Transplantation and Advanced Specialized Therapies (IRCCS ISMETT), Palermo, Italy.
Front Med (Lausanne). 2021 Sep 23;8:746298. doi: 10.3389/fmed.2021.746298. eCollection 2021.
The prevalence of end-stage liver diseases has reached very high levels globally. The election treatment for affected patients is orthotopic liver transplantation, which is a very complex procedure, and due to the limited number of suitable organ donors, considerable research is being done on alternative therapeutic options. For instance, the use of cell therapy, such as the transplantation of hepatocytes to promote liver repair/regeneration, has been explored, but standardized protocols to produce suitable human hepatocytes are still limited. On the other hand, liver progenitor and multipotent stem cells offer potential cell sources that could be used clinically. Different studies have reported regarding the therapeutic effects of transplanted mesenchymal stromal/stem cells (MSCs) on end-stage liver diseases. Moreover, it has been shown that delivery of MSC-derived conditioned medium (MSC-CM) can reduce cell death and enhance liver proliferation in fulminant hepatic failure. Therefore, it is believed that MSC-CM contains many factors that probably support liver regeneration. In our work, we used an model of human liver organoids to study if the paracrine components secreted by human amnion-derived MSCs (hAMSCs) affected liver stem/progenitor cell differentiation. In particular, we differentiated liver organoids derived from bipotent EpCAM human liver cells and tested the effects of hAMSC secretome, derived from both two-dimensional (2D) and three-dimensional (3D) hAMSC cultures, on that model. Our analysis showed that conditioned medium (CM) produced by 3D hAMSCs was able to induce an over-expression of mature hepatocyte markers, such as ALB, NTCP, and CYP3A4, compared with both 2D hAMSC cultures and the conventional differentiation medium (DM). These data were confirmed by the over-production of ALB protein and over-activity of CYP3A4 observed in organoids grown in 3D hAMSC-CM. Liver repair dysfunction plays a role in the development of liver diseases, and effective repair likely requires the normal functioning of liver stem/progenitor cells. Herein, we showed that hAMSC-CM produced mainly by 3D cultures had the potential to increase hepatic stem/progenitor cell differentiation, demonstrating that soluble factors secreted by those cells are potentially responsible for the reaction. This work shows a potential approach to improve liver repair/regeneration also in a transplantation setting.
终末期肝病在全球的患病率已达到很高水平。针对受影响患者的首选治疗方法是原位肝移植,这是一个非常复杂的过程,而且由于合适器官供体数量有限,人们正在对替代治疗方案进行大量研究。例如,已经探索了细胞疗法的应用,如移植肝细胞以促进肝脏修复/再生,但生产合适的人肝细胞的标准化方案仍然有限。另一方面,肝祖细胞和多能干细胞提供了可用于临床的潜在细胞来源。不同的研究报告了移植间充质基质/干细胞(MSC)对终末期肝病的治疗效果。此外,已经表明,递送MSC衍生的条件培养基(MSC-CM)可以减少暴发性肝衰竭中的细胞死亡并增强肝脏增殖。因此,人们认为MSC-CM含有许多可能支持肝脏再生的因子。在我们的工作中,我们使用人肝类器官模型来研究人羊膜来源的MSC(hAMSC)分泌的旁分泌成分是否影响肝干细胞/祖细胞的分化。特别是,我们分化了源自双能EpCAM人肝细胞的肝类器官,并测试了源自二维(2D)和三维(3D)hAMSC培养物的hAMSC分泌组对该模型的影响。我们的分析表明,与2D hAMSC培养物和传统分化培养基(DM)相比,3D hAMSC产生的条件培养基(CM)能够诱导成熟肝细胞标志物如ALB、NTCP和CYP3A4的过表达。在3D hAMSC-CM中生长的类器官中观察到的ALB蛋白的过量产生和CYP3A4的过度活性证实了这些数据。肝脏修复功能障碍在肝病的发展中起作用,有效的修复可能需要肝干细胞/祖细胞的正常功能。在此,我们表明主要由3D培养物产生的hAMSC-CM具有增加肝干细胞/祖细胞分化的潜力,表明这些细胞分泌的可溶性因子可能是这种反应的原因。这项工作展示了一种在移植环境中改善肝脏修复/再生的潜在方法。